BeautyHealth Beats Expectations, Raises Guidance
Update: 2025-11-08
Description
BeautyHealths Q3 earnings for 2025 showed a 10.3% sales drop, but beat Wall Streets expectations, with a GAAP loss per share of nine cents. The company raised its full-year revenue guidance to $296.5 million, surpassing analyst predictions for adjusted EBITDA at $8.9 million. The positive market reaction was due to stabilizing the Hydrafacial business, focusing on high-margin consumables, and successful operational execution. Looking ahead, BeautyHealth plans to increase consumable usage, innovate products, and maintain operational discipline, aiming to expand the Hydrafacial device footprint and capture more recurring revenue.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
